microfluidics
Bioké Inks Distribution Agreements With Scale Biosciences, Atrandi Biosciences
The deals add to the Dutch distributor's single-cell sequencing and microfluidics technology offerings in the Netherlands, Belgium, and Luxembourg.
Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.
Angle, BioView Partner to Develop Quantitative HER2 Assay Using Circulating Tumor Cells
The companies said recent developments in HER2-targeted therapies have created new commercial opportunities for a blood-based test.
Samplix Garners €10M in Funding From European Innovation Council
Copenhagen-based Samplix will use the accelerator investment to develop approaches for the functional characterization of single cells.
Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech
The company, formerly called Droplet Genomics, will apply the funds to establish a US customer support team and to advance commercialization of its droplet-based platforms.